Teva Pharmaceutical Industries EBITDA Margin 2010-2024 | TEVA

Teva Pharmaceutical Industries ebitda margin for the quarter ending June 30, 2024 was 12.01%.

  • Teva Pharmaceutical Industries average ebitda margin for 2023 was 2.09%, a 8.33% increase from 2022.
  • Teva Pharmaceutical Industries average ebitda margin for 2022 was 2.28%, a 214.57% decline from 2021.
  • Teva Pharmaceutical Industries average ebitda margin for 2021 was -1.99%, a 136.38% decline from 2020.

Ebitda margin can be defined as earnings before interest, taxes, depreciation and amortization as a portion of total revenue.

Teva Pharmaceutical Industries EBITDA Margin 2010-2024 | TEVA

  • Teva Pharmaceutical Industries average ebitda margin for 2023 was 2.09%, a 8.33% increase from 2022.
  • Teva Pharmaceutical Industries average ebitda margin for 2022 was 2.28%, a 214.57% decline from 2021.
  • Teva Pharmaceutical Industries average ebitda margin for 2021 was -1.99%, a 136.38% decline from 2020.

Ebitda margin can be defined as earnings before interest, taxes, depreciation and amortization as a portion of total revenue.
Related Stocks
Company NameMarket
Cap
Dr Reddy's Laboratories (RDY)$13.1B
BridgeBio Pharma (BBIO)$5B
Bausch Health Cos (BHC)$3B
Amphastar Pharmaceuticals (AMPH)$2.4B
Supernus Pharmaceuticals (SUPN)$1.8B
Taysha Gene Therapies (TSHA)$449M
Personalis (PSNL)$315M
Assembly Biosciences (ASMB)$117M
Acasti Pharma (ACST)$28M
Sol-Gel Technologies (SLGL)$20M
Evoke Pharma (EVOK)$4M
Teligent (TLGT)$0M